Theravance (THRX) Halted Ahead of FDA Advisory Committee Meeting on 204275-S001 sNDA
Tweet Send to a Friend
Theravance (Nasdaq: THRX) announced that NASDAQ halted trading of the Company's common stock this morning, March 19, 2015. The U.S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
